Injectafer (ferric carboxymaltose) Disease Interactions
There are 3 disease interactions with Injectafer (ferric carboxymaltose):
Ferric carboxymaltose (applies to Injectafer) hypertension
Moderate Potential Hazard, Moderate plausibility.
Transient elevation of blood pressure has been reported in clinical trials in patients receiving ferric carboxymaltose. These elevations generally occurred immediately after dosing and resolved in 30 minutes. Patients should be monitored for symptoms or signs of hypertension following treatment.
Ferric carboxymaltose (applies to Injectafer) hypophosphatemia
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Malabsorption Syndrome
Patients with malabsorption of fat-soluble vitamins or phosphate, or using medications affection proximal renal tubular function, hyperparathyroidism, vitamin D deficiency, or malnutrition may experience symptomatic hypophosphatemia. Cases occur mostly after repeat exposure. Most cases resolved within 3 months. Monitor serum phosphate in at risk patiens requiring repeat treatment.
Ferrous salts (applies to Injectafer) hypersensitivity reactions
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Allergies
Serious hypersensitivity reactions, including anaphylaxis- type reactions, some of which have been life-threatening have been reported in patients using some injection iron products. Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. These products should be administered cautiously, especially in patients with a history of significant allergies. Patients should be monitored during and at least 30 minutes after the administration. Epinephrine should be immediately available in the event of acute hypersensitivity reactions.
Injectafer (ferric carboxymaltose) drug interactions
There are 28 drug interactions with Injectafer (ferric carboxymaltose)
Injectafer (ferric carboxymaltose) alcohol/food interactions
There is 1 alcohol/food interaction with Injectafer (ferric carboxymaltose)
More about Injectafer (ferric carboxymaltose)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Interactions
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: iron products
- FDA Approval History
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.